![Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a complex concept | Nature Reviews Neurology Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a complex concept | Nature Reviews Neurology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41582-022-00700-2/MediaObjects/41582_2022_700_Fig1_HTML.png)
Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a complex concept | Nature Reviews Neurology
![Frontiers | Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse? Frontiers | Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?](https://www.frontiersin.org/files/Articles/572186/fimmu-11-572186-HTML/image_m/fimmu-11-572186-g001.jpg)
Frontiers | Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?
![Positron emission tomography in multiple sclerosis — straight to the target | Nature Reviews Neurology Positron emission tomography in multiple sclerosis — straight to the target | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-021-00537-1/MediaObjects/41582_2021_537_Fig1_HTML.png)
Positron emission tomography in multiple sclerosis — straight to the target | Nature Reviews Neurology
![When encephalitogenic T cells collaborate with microglia in multiple sclerosis | Nature Reviews Neurology When encephalitogenic T cells collaborate with microglia in multiple sclerosis | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-019-0253-6/MediaObjects/41582_2019_253_Fig1_HTML.png)
When encephalitogenic T cells collaborate with microglia in multiple sclerosis | Nature Reviews Neurology
![Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-021-00581-x/MediaObjects/41582_2021_581_Fig1_HTML.png)
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology
![Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrd3248/MediaObjects/41573_2010_Article_BFnrd3248_Fig1_HTML.jpg)